Vasc Spec Int.  2017 Jun;33(2):55-58. 10.5758/vsi.2017.33.2.55.

Long Term Outcomes of Femorofemoral Crossover Bypass Grafts

Affiliations
  • 1Department of Surgery, Inha University Hospital, Incheon, Korea.
  • 2Division of Vascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. dikim@skku.edu
  • 3Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Abstract

PURPOSE
Femorofemoral crossover bypass (FCB) is a good procedure for patients with unilateral iliac artery disease. There are many articles about the results of FCB, but most of them were limited to 5 years follow-up. The purpose of our study was to analysis the results of FCB with a 10-year follow-up period.
MATERIALS AND METHODS
Between January 1995 and December 2010, 133 patients were operated in Samsung Medical Center (median follow-up: 58.8 months). We retrospectively analysed patient characteristics, the preoperative treatment, the operative procedure, and material used.
RESULTS
The indications for FCB were claudication in 110 and critical limb ischemia in 23 patients. Three patients were died due to myocardiac infarction, intracranial hemorrhage, and acute respiratory failure within 30 days after surgery. The one-year primary and secondary patency rates were 89% and 97%, the 5-year primary and secondary patency rates were 70% and 85%, and the 10-year primary and secondary patency rates were 31% and 67%. The 5-year and 10-year limb salvage rates were 97% and 95%, respectively.
CONCLUSION
Our long term analysis suggests that FCB might be a valuable alternative treatment modality in patients with unilateral iliac artery disease.

Keyword

Femorofemoral; Bypass; Iliac artery; Vascular patency

MeSH Terms

Extremities
Follow-Up Studies
Humans
Iliac Artery
Infarction
Intracranial Hemorrhages
Ischemia
Limb Salvage
Respiratory Insufficiency
Retrospective Studies
Surgical Procedures, Operative
Transplants*
Vascular Patency
Full Text Links
  • VSI
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr